MaxLinear, Inc. (NASDAQ:MXL – Get Free Report) shares reached a new 52-week low during trading on Friday . The company traded as low as $11.01 and last traded at $11.11, with a volume of 373332 shares traded. The stock had previously closed at $11.94.
Wall Street Analyst Weigh In
MXL has been the subject of several recent research reports. Benchmark reiterated a “buy” rating and set a $28.00 target price on shares of MaxLinear in a research report on Thursday, January 30th. Susquehanna reduced their target price on MaxLinear from $25.00 to $23.00 and set a “neutral” rating on the stock in a report on Thursday, January 30th. Wells Fargo & Company upped their price target on MaxLinear from $19.00 to $20.00 and gave the company an “equal weight” rating in a research note on Thursday, January 30th. Needham & Company LLC reissued a “hold” rating on shares of MaxLinear in a research note on Thursday, January 30th. Finally, Northland Securities boosted their price objective on shares of MaxLinear from $25.00 to $27.50 and gave the company an “outperform” rating in a report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $25.50.
Check Out Our Latest Report on MXL
MaxLinear Price Performance
MaxLinear (NASDAQ:MXL – Get Free Report) last released its quarterly earnings results on Wednesday, January 29th. The semiconductor company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.13) by ($0.14). MaxLinear had a negative net margin of 68.01% and a negative return on equity of 21.94%. As a group, research analysts anticipate that MaxLinear, Inc. will post -0.37 EPS for the current fiscal year.
Institutional Trading of MaxLinear
Institutional investors have recently modified their holdings of the company. The Manufacturers Life Insurance Company raised its position in MaxLinear by 3,698.1% in the 4th quarter. The Manufacturers Life Insurance Company now owns 1,525,419 shares of the semiconductor company’s stock valued at $30,173,000 after buying an additional 1,485,256 shares during the last quarter. Point72 Hong Kong Ltd acquired a new stake in shares of MaxLinear in the fourth quarter valued at approximately $25,659,000. Schonfeld Strategic Advisors LLC bought a new stake in shares of MaxLinear in the fourth quarter worth $25,027,000. Point72 Asset Management L.P. boosted its holdings in MaxLinear by 1,813.5% during the fourth quarter. Point72 Asset Management L.P. now owns 1,256,300 shares of the semiconductor company’s stock worth $24,850,000 after purchasing an additional 1,190,647 shares during the last quarter. Finally, Assenagon Asset Management S.A. grew its position in MaxLinear by 339.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,250,769 shares of the semiconductor company’s stock valued at $24,740,000 after purchasing an additional 966,468 shares in the last quarter. 90.79% of the stock is currently owned by institutional investors.
MaxLinear Company Profile
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
See Also
- Five stocks we like better than MaxLinear
- What is a Dividend King?
- MarketBeat Week in Review – 03/24 – 03/28
- How to Capture the Benefits of Dividend Increases
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.